# FDA Inspection 989732 - Biomat USA, Inc. - September 29, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/804796ed-7e1f-493d-9323-a16977a92b1a
Source feed: FDA_Inspections

> FDA Inspection 989732 for Biomat USA, Inc. on September 29, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 989732
- Company Name: Biomat USA, Inc.
- Inspection Date: 2016-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1078956 - 2018-12-19](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d8551ff5-51a9-48ec-bf41-54aec128329d)
- [FDA Inspection 783491 - 2012-05-21](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/62c5a6b7-04e7-4ec6-9a84-c0b55e9c0dd1)
- [FDA Inspection 681867 - 2010-09-13](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0900d602-7d48-4c16-ad82-743baf090545)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/1dd1ff51-0ff7-4d7e-abfb-a91b174fbcac

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d